| RRC ID |
88039
|
| 著者 |
Zhang L, Yu J, Gao X, Yan Y, Wang X, Shi H, Fang M, Liu Y, Kim YB, Zhu H, Wu X, Huang C, Fan S.
|
| タイトル |
Targeting farnesoid X receptor as aging intervention therapy.
|
| ジャーナル |
Acta Pharm Sin B
|
| Abstract |
Environmental toxicants have been linked to aging and age-related diseases. The emerging evidence has shown that the enhancement of detoxification gene expression is a common transcriptome marker of long-lived mice, Drosophila melanogaster, and Caenorhabditis elegans. Meanwhile, the resistance to toxicants was increased in long-lived animals. Here, we show that farnesoid X receptor (FXR) agonist obeticholic acid (OCA), a marketed drug for the treatment of cholestasis, may extend the lifespan and healthspan both in C. elegans and chemical-induced early senescent mice. Furthermore, OCA increased the resistance of worms to toxicants and activated the expression of detoxification genes in both mice and C. elegans. The longevity effects of OCA were attenuated in Fxr-/- mice and Fxr homologous nhr-8 and daf-12 mutant C. elegans. In addition, metabolome analysis revealed that OCA increased the endogenous agonist levels of the pregnane X receptor (PXR), a major nuclear receptor for detoxification regulation, in the liver of mice. Together, our findings suggest that OCA has the potential to lengthen lifespan and healthspan by activating nuclear receptor-mediated detoxification functions, thus, targeting FXR may offer to promote longevity.
|
| 巻・号 |
15(3)
|
| ページ |
1359-1382
|
| 公開日 |
2025-3-1
|
| DOI |
10.1016/j.apsb.2025.01.006
|
| PII |
S2211-3835(25)00011-5
|
| PMID |
40370561
|
| PMC |
PMC12069902
|
| リソース情報 |
| 線虫 |
tm331
tm1800
tm420 |
